JZU CLINIC FOR CHILDREN'S DISEASES has floated a tender for Procurement of Drugs for Conditional Budget 2024 Biological Therapy (Adalimumab, Eltrombopag, Dinutuximab Beta, Etanercept, Anakinra, Infliximab) Somatotropin Hormone (Somatropin) and Inhalation Therapy for Cystic.... The project location is Macedonia and the tender is closing on 25 Apr 2024. The tender notice number is 05694/2024, while the TOT Ref Number is 99332090. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Expired Tender

Procurement Summary

Country : Macedonia

Summary : Procurement of Drugs for Conditional Budget 2024 Biological Therapy (Adalimumab, Eltrombopag, Dinutuximab Beta, Etanercept, Anakinra, Infliximab) Somatotropin Hormone (Somatropin) and Inhalation Therapy for Cystic...

Deadline : 25 Apr 2024

Other Information

Notice Type : Tender

TOT Ref.No.: 99332090

Document Ref. No. : 05694/2024

Competition : ICB

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Purchaser : JZU CLINIC FOR CHILDREN'S DISEASES
Address: Vodnjanska 17
City and postal code: Skopje
Contact person: Arta Cahili
phone/fax:3226712/
Macedonia
Email :ramadani.arta993@gmail.com

Tender Details

Procurement of drugs for Conditional budget 2024 Biological therapy (Adalimumab, Eltrombopag, Dinutuximab beta, Etanercept, Anakinra, Infliximab) Somatotropin hormone (Somatropin) and Inhaler therapy for Cystic fibrosis (Tobramycin, Dornase alfa, Colistin (colistimethate))

Detailed description of the subject of the agreement
CPV Descriptions: Pharmaceutical products

Documents

 Tender Notice

Document_1.doc